KLKnut Asbjørn Rise Langlo

Knut Asbjørn Rise Langlo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Knut Asbjørn Rise Langlo has a total of 65 co-authors. Here are the top co-authors by number of shared publications:

  • Stein Ivar Hallan

    Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway

    5 shared publications
  • Michael G. Shlipak

    Kidney Health Research Collaborative, Department of Medicine University of California San Francisco San Francisco California USA

    3 shared publications
  • Ulrik Wisløff

    Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway

    3 shared publications
  • Dorthe Stensvold

    Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway

    2 shared publications
  • Håvard Dalen

    Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway

    2 shared publications
  • Inger-Lise Aamot Aksetøy

    Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, NTNU , Postbox 8905, Prinsesse Kristinas gate 3, 7030 Trondheim , Norway

    2 shared publications

Latest Publications

  • Open Access

    Incidence and outcome of acute kidney injury in open abdomen treatment following open surgery for ruptured abdominal aortic aneurysm

    by Henriette Fagertun, Knut A. Rise Langlo, Pål Klepstad, Skule Mo, Tor-Arne Hegvik, Linn Åldstedt Nyrønning, Martin Björck, Arne Seternes

    Background and aims: Acute kidney injury (AKI) is a key contributor to multiorgan dysfunction and mortality in ruptured abdominal aortic aneurysm (rAAA). Intra-abdominal hypertension and abdominal compartment syndrome (ACS), complications potentially resulting in AKI, can be prevented or managed with open abdomen treatment (OAT). Using consensus-based definitions, this study characterizes AKI in rAAA patients managed with OAT and examines the impact of abdominal wall closure on renal function. Methods: A single-center observational cohort study including all consecutive patients treated with OAT after open surgical repair for rAAA from September 2009 to January 2024. AKI was diagnosed and staged based on urine output (UO) and S-creatinine (SCr) as defined by the KDIGO classification, reassessed at closure of the abdomen and at discharge. Results: Seventy-three patients (mean age 73 years, 85% male) received OAT, prophylactically in 63 (85%) and due to ACS in 11 (15%). AKI occurred in 71 patients (97%) at a median of 2 (IQR, 2–3) days of admittance; 22 patients (30%) had stage 3 AKI, including 13 (18%) needing renal replacement therapy. The multivariable logistic regression showed SCr at admittance (p = .034) and perioperative diuresis (p = .018) as predictors of stage 3 AKI. The UO criterion diagnosed more patients than SCr alone (p = .001). Abdominal closure did not aggravate kidney function. In AKI stage 3, 90-day survival was 46% versus 80% in AKI stage 1 and 2 (p = .008). Forty-seven out of 51 survivors (92%) had resolution of their AKI before discharge. Conclusions: Defined by KDIGO, AKI developed in 71/73 (97%) of rAAA patients with OAT after surgical repair. UO was the most sensitive parameter. AKI was diagnosed at median 2 days of admittance and was transient in majority of survivors. There was no aggravation of kidney function at delayed primary abdominal closure.

  • Comparing Age- and Sex-Specific Reference Values of eGFR between the United States and Europe

    by Megan E. Astley, Alberto Ortiz, Stein Hallan, Giovanni Gambaro, Juan-Jesus Carrero, Natalie Ebert, Bjørn Odvar Eriksen, Anne-Laure Faucon, Pietro Manuel Ferraro, Till Ittermann, et al.

    The extent to which eGFR varies across populations, in the absence of risk factors and comorbidities associated with kidney disease, remains uncertain. We aimed to develop eGFR reference values in healthy American adults and to compare them with previously described European eGFR reference values. This cross-sectional study compared newly described age-specific and sex-specific creatinine-based eGFR reference values from over 9000 healthy Americans from National Health and Nutrition Examination Survey with previously described eGFR reference values from over 1.5 million healthy individuals in the European CKD Burden Consortium. Health status was based on 14 criteria related to comorbidities, lifestyle factors, and medication use. eGFR was calculated using the European Kidney Function Consortium equation and modeled over the age span and by sex using a generalized additive model. The median eGFR in both 20-year-old American and European men was 98 ml/min per 1.73 m 2 . In both 20-year-old American and European women, the median eGFR was 101 ml/min per 1.73 m 2 . eGFR started to decrease at age 40 years, a result of the structure of the European Kidney Function Consortium equation. By age 79 years, the median eGFR in American and European men was 68 and 67 ml/min per 1.73 m 2 , respectively. The median eGFR in 79-year-old American and European women was 63 and 64 ml/min per 1.73 m 2 , respectively. When removing the effect of comorbidities, lifestyle factors and medication use associated with kidney function, achieved by restricting the analyses to individuals who did not have a presence or history of certain criteria, the distribution of eGFR was similar between healthy Americans and Europeans. This supports the notion that eGFR reference values may be generalizable to populations they were not derived from.


  • Open Access

    Physiological assessment of left ventricular size indexed by peak oxygen uptake across sporting disciplines

    by Jana Schellenberg, Lynn Matits, Johannes Kersten, Daniel Alexander Bizjak, Johannes Kirsten, Thomas Fremo, Arnt Erik Tjønna, Knut Skovereng, Øyvind Sandbakk, Inger-Lise Aamot Aksetøy, et al.

    Aims: Left ventricular (LV) enlargement is a common training-induced adaptation in athletes, particularly in endurance sports. Previous research indicates that indexing LV volumes and mass to absolute peak oxygen uptake (VO₂peak) better reflects physiological adaptation than traditional indexing to body surface area (BSA). Therefore, we investigated whether indexing LV end-diastolic volume (LVEDV) and mass to VO2peak could eliminate differences in LV size among athletes from different sport categories (endurance, mixed, power, and technical). Methods and results: This analysis included 70 athletes from the multicenter COSMO-S in Germany and 15 elite endurance athletes from Norway. All participants (29 ± 8 years, 52 male) underwent echocardiography and cardiopulmonary exercise testing. In regression analyses, VO2peak (L/min) accounted for a significantly greater proportion of the variance in LVEDV than BSA (R2 0.64 vs. 0.19, P < 0.001), while this difference was not significant for LV mass (R2 0.54 vs. 0.36, P = 0.06). When indexed to BSA, both LVEDV and LV mass revealed significant differences across sports (both P ≤ 0.019), that disappeared when indexed to VO₂peak (all P ≥ 0.40). In a cohort of 12 dilated cardiomyopathy (DCM) patients serving as a pathological reference group, indexing LVEDV and LV mass to VO2peak better differentiated DCM patients from athletes than indexing to BSA. Conclusion: Indexing LV size to VO₂peak may provide a more physiological interpretation of cardiac adaptations in athletes and reduce sport-specific differences due to better consideration of training-induced adaptations. These findings should be replicated in larger cohorts and tested for the ability to detect subtle pathologies.


  • Top Cited Papers
    Open Access

    Long-Term Physical Exercise for Preventing CKD in Older Adults

    by Stein I. Hallan, Marius A. Øvrehus, Michael G. Shlipak, O. Alison Potok, Solfrid Romundstad, Nils P. Aspvik, Ulrik Wisløff, Joachim H. Ix, Dorthe Stensvold, Knut A. Langlo

    Key Points: Physical exercise mitigates several kidney-related pathophysiological pathways, yet its effect on kidney function remains underexplored. This randomized clinical trial found that high-intensity interval training significantly reduced the risk of rapid eGFR decline in older adults. Physical exercise can preserve kidney function, benefiting public health and individual patient outcomes similar to other cardiovascular diseases. Background: CKD is a growing global public health issue. Physical exercise mitigates several kidney-related pathophysiological pathways, yet its effect on kidney function remains underexplored. We investigated the dose-response effect of physical exercise on kidney function preservation in older adults. Methods: We conducted a post hoc analysis of the Generation 100 Study, a 5-year open-label, randomized, parallel-arm clinical trial conducted from 2012 to 2018 in Trondheim, Norway. All inhabitants aged 70–77 years were invited ( n =6966). Main exclusion criteria were dementia; severe, uncontrolled cardiovascular disease or hypertension; or conditions precluding exercise. The control group ( n =385) received information on national physical activity recommendations. Intervention groups underwent supervised moderate-intensity continuous training (70% of peak heart rate) for 50 minutes ( n =380) twice weekly for 5 years or high-intensity interval training (90% of peak heart rate) for 4 minutes ×4 ( n =391) twice weekly for 5 years. The primary outcome was cystatin C–based rapid eGFR decline (>5 ml/min per 1.73 m 2 per year). Results: A total of 1156 participants were randomized, with median (interquartile range) age 72 (3) years and eGFR 95 (20) ml/min per 1.73 m 2 . Oxygen uptake increased by 1.8, 2.3, and 3.3 ml/kg per minutes in the control, moderate-intensity, and high-intensity groups, respectively. Rapid eGFR decline occurred in 117 (30%), 108 (28%), and 92 (23%) participants, respectively. Compared with controls, relative risk (RR) was 0.93 (95% confidence interval [CI], 0.75 to 1.16) for the moderate-intensity and 0.75 (95% CI, 0.59 to 0.95) for high-intensity groups, demonstrating a significant dose-response relationship ( P for trend 0.02). In observational analyses, participants with decreasing moderate-to-vigorous intensity activity (>−20 min/wk) had RR 1.30 (95% CI, 0.93 to 1.83) for rapid eGFR decline, while those with increasing activity (>+20 min/wk) had RR 0.73 (95% CI, 0.53 to 0.99) compared with stable activity after adjusting for baseline age, sex, peak oxygen uptake, and eGFR. Conclusions: High-intensity interval training significantly reduced the risk of rapid eGFR decline in older adults. Clinical Trial registry name and registration number: ClinicalTrials.gov: NCT01666340.


  • Open Access

    Indexing cardiac volumes for peak oxygen uptake to improve differentiation of physiological and pathological remodeling: from elite athletes to heart failure patients

    by Jon Magne Letnes, Bjarne Martens Nes, Knut Asbjørn Rise Langlo, Inger-Lise Aamot Aksetøy, Kari Margrethe Lundgren, Knut Skovereng, Øyvind Sandbakk, Ulrik Wisløff, Håvard Dalen

    Cardiovascular structures adapt to meet metabolic demands, but current methodology for indexing by body size does not accurately reflect such variations. Therefore, we aimed to investigate how left ventricular end-diastolic volume (LVEDV) and left atrial maximal volume (LAVmax) are associated with absolute (L/min) peak oxygen uptake (VO2peak) and fat-free mass (FFM) compared to body surface area (BSA). We subsequently assessed the impact of indexing by absolute VO2peak, FFM, and BSA to discriminate pathological from physiological remodeling. We used data from 1190 healthy adults to explore relationships for BSA, FFM, and absolute VO2peak with LVEDV and LAVmax by regression and correlation analyses. We then compared these indexing methods for classification to normalcy/pathology in 61 heart failure patients and 71 endurance athletes using the chi-squared and Fisher exact tests and the net reclassification and integrated discrimination indices. Absolute VO2peak correlated strongly with LVEDV, explaining 52% of variance vs. 32% for BSA and 44% for FFM. Indexing LVEDV for VO2peak improved discrimination between heart failure patients and athletes on top of indexing to BSA. Seventeen out of 18 athletes classified to pathology by BSA were reclassified to normalcy by VO2peak indexing (P < 0.001), while heart failure patients were reclassified to pathology (39–95%, P < 0.001). All indexing methods explained below 20% of the variance in LAVmax in univariate models. Indexing LVEDV to VO2peak improves the ability to differentiate physiological and pathological enlargement. The LVEDV to absolute VO2peak ratio may be a key index in diagnosing heart failure and evaluating the athlete’s heart. Development of reference ranges for left ventricular end-diastolic volume (LVEDV) by absolute peak oxygen uptake (VO2peak) (left panel), visualization of the impact of differentiation between chamber dilatation due to heart failure and physiological remodeling (middle panel), and impact on interpretation of LVEDV normalcy (right panel). BSA = body surface area; CPET = cardiopulmonary exercise testing.


  • Open Access

    Cardiorenal Syndrome and the Association with Fitness: Data from a Telerehabilitation Randomized Clinical Trial

    by Knut Asbjørn Rise Langlo, Kari Margrethe Lundgren, Paolo Zanaboni, Rune Mo, Øyvind Ellingsen, Stein Ivar Hallan, Inger-Lise Aamot Aksetøy, Håvard Dalen

    Aims: To investigate the associations of cardiorespiratory fitness with cardiac, vascular, renal and cardiorenal characteristics in chronic heart failure in a telerehabilitation randomized clinical trial. Secondly, to evaluate the associations of cardiorenal syndrome with the effects of exercise. Methods and results: Sixty-nine heart failure patients attended baseline examination, and 61 patients were randomly assigned 1:1 to 3-month telerehabilitation or control. Data were collected at baseline and 3-month post-intervention, including echocardiography and vascular ultrasound, laboratory tests, exercise test with peak oxygen consumption (VO2peak) measurement and 6-min walk test (6MWT). Baseline VO2peak and 6MWT distance was 0.85 mL*min−1*kg−1 lower and 20 m shorter per 10 mL/min/1.73m2 lower estimated glomerular filtration rate (both P < 0.001). Heart failure patients with cardiorenal syndrome had 3.5 (1.1) mL*min−1*kg−1 lower VO2peak and diastolic dysfunction grade 2–3, and elevated filling pressure was >50% more common compared with those without (all P < 0.05). At the 3-month post-intervention follow-up, only the non-CRS patients in the intervention group increased VO2peak (0.73 (0.51) mL*min−1*kg−1), whereas VO2peak in the CRS subpopulation of controls decreased (−1.34 (0.43) mL*min−1*kg−1). Cardiorenal syndrome was associated with a decrease in VO2peak in CRS patients compared with non-CRS patients, −0.91 (0.31) vs. 0.39 (0.35) mL*min−1*kg−1 respectively, P = 0.013. Conclusions: Cardiorenal syndrome was negatively associated with VO2peak and 6MWT distance in chronic HF, and the associations were stronger than for heart failure phenotypes and other characteristics. The effect of exercise was negatively associated with cardiorenal syndrome. Exercise seems to be as important in heart failure patients with cardiorenal syndrome, and future studies should include CRS patients to reveal the most beneficial type of exercise.


  • Open Access

    Circulating microRNAs May Serve as Biomarkers for Hypertensive Emergency End-Organ Injuries and Address Underlying Pathways in an Animal Model

    by Knut Asbjørn Rise Langlo, Gustavo Jose Justo Silva, Tina Syvertsen Overrein, Volker Adams, Ulrik Wisløff, Håvard Dalen, Natale Rolim, Stein Ivar Hallan

    There is an incomplete understanding of the underlying pathophysiology in hypertensive emergencies, where severely elevated blood pressure causes acute end-organ injuries, as opposed to the long-term manifestations of chronic hypertension. Furthermore, current biomarkers are unable to detect early end-organ injuries like hypertensive encephalopathy and renal thrombotic microangiopathy. We hypothesized that circulating microRNAs (c-miRs) could identify acute and chronic complications of severe hypertension, and that combinations of c-miRs could elucidate important pathways involved. We studied the diagnostic accuracy of 145 c-miRs in Dahl salt-sensitive rats fed either a low-salt (N = 20: 0.3% NaCl) or a high-salt (N = 60: 8% NaCl) diet. Subclinical hypertensive encephalopathy and thrombotic microangiopathy were diagnosed by histopathology. In addition, heart failure with preserved ejection fraction was evaluated with echocardiography and N-terminal pro-brain natriuretic peptide; and endothelial dysfunction was studied using acetylcholine-induced aorta ring relaxation. Systolic blood pressure increased severely in animals on a high-salt diet (high-salt 205 ± 20 mm Hg vs. low-salt 152 ± 18 mm Hg, p < 0.001). Partial least squares discriminant analysis revealed 68 c-miRs discriminating between animals with and without hypertensive emergency complications. Twenty-nine c-miRs were strongly associated with hypertensive encephalopathy, 24 c-miRs with thrombotic microangiopathy, 30 c-miRs with heart failure with preserved ejection fraction, and 28 c-miRs with endothelial dysfunction. Hypertensive encephalopathy, thrombotic microangiopathy and heart failure with preserved ejection fraction were associated with deviations in many of the same c-miRs, whereas endothelial dysfunction was associated with a different set of c-miRs. Several of these c-miRs demonstrated fair to good diagnostic accuracy for a composite outcome of hypertensive encephalopathy, thrombotic microangiopathy and heart failure with preserved ejection fraction in receiver-operating-curve analyses (area-under-curve 0.75–0.88). Target prediction revealed an enrichment of genes related to several pathways relevant for cardiovascular disease (e.g., mucin type O-glycan biosynthesis, MAPK, Wnt, Hippo, and TGF-beta signaling). C-miRs could potentially serve as biomarkers of severe hypertensive end-organ injuries and elucidate important pathways involved.